Cardurion Pharmaceuticals Revenue and Competitors

Boston, MA USA

Location

#5934

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Cardurion Pharmaceuticals's estimated annual revenue is currently $8.1M per year.(i)
  • Cardurion Pharmaceuticals's estimated revenue per employee is $155,000

Employee Data

  • Cardurion Pharmaceuticals has 52 Employees.(i)
  • Cardurion Pharmaceuticals grew their employee count by 37% last year.

Cardurion Pharmaceuticals's People

NameTitleEmail/Phone
1
Founder and ChairmanReveal Email/Phone
2
VP, Information TechnologyReveal Email/Phone
3
VP, Program Management and Portfolio StrategyReveal Email/Phone
4
VP, Head Translational MedicineReveal Email/Phone
5
SVP and General CounselReveal Email/Phone
6
VP - Head QualityReveal Email/Phone
7
Head the Office Project ManagementReveal Email/Phone
8
VP FinanceReveal Email/Phone
9
Head, Cardurion Pharmaceuticals K.KReveal Email/Phone
10
VP, Information TechnologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Cardurion Pharmaceuticals?

Cardurion is a clinical-stage cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. Cardurion's product pipeline includes our lead clinical asset, CRD-733, a PDE-9 inhibitor with the potential to improve cardiac function in heart failure patients. Cardurion has an exclusive licensing agreement with Astellas for the development and commercialization of CRD-733. Additionally, Cardurion has a strong cardiovascular development partnership with Takeda which is fueling drug discovery and preclinical development work being conducted in our internal research laboratories.

keywords:N/A

N/A

Total Funding

52

Number of Employees

$8.1M

Revenue (est)

37%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cardurion Pharmaceuticals News

2022-02-22 - Cardurion Pharmaceuticals Enhances Leadership Team with ...

Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.8M5224%N/A
#2
$6.8M52N/AN/A
#3
$15.1M52-4%N/A
#4
$9.8M5227%N/A
#5
$10.3M52-9%N/A